Lassa fever virus (LASV) cell sorting for monoclonal antibody discovery for usamriid

Award Notice Posted

Solicitation number
HT942524P0015
Agency
Awarded
to Eitr Biologics, Inc.
Set-aside
Total Small Business

Opportunity facts

Contract number
HT942524P0015 Federal contract award
Place of performance
San Diego, California 92121, United States

Notice details come from SAM.gov. Updated .

About this opportunity

EITR Biologics, Inc. was awarded a firm fixed price contract valued at $1,504,443.84 by the Defense Health Agency on December 6, 2023. The contract is for the sorting of peripheral blood mononuclear cells from Lassa Fever virus survivors to discover and produce monoclonal antibodies, which will then be assessed through in-vitro and in-vivo assays in support of the U.S. Army Medical Research Institute of Infectious Diseases. This award resulted from a competitive small business set-aside procurement.

Notice text

EITR Biologics, Inc. received a Firm Fixed Price award for the sorting of peripheral blood mononuclear cells from Lassa Fever virus survivors to discover and product monoclonal antibodies for assessment in in-vitro and in-vivo assays in support of USAMRIID. This award was a result of a Competitive, 100% Small Business Set-Aside.

Awarded contract HT942524P0015 to EITR BIOLOGICS, INC. for 1504443.84 on 2023-12-06.

Notice history

Notice Type Posted
This notice Award Award Notice
Lassa fever virus (LASV) cell sorting for monoclonal antibody discovery for usamriid - amendment 0001 - questions from offerors Latest solicitation Solicitation

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors